EGF activates highly selective estrogen-responsive reporter plasmids by an ER-independent pathway

Molecular and Cellular Endocrinology

Volumn 159, Issue 1-2, 2000, Pages 53-62

  Gehm, Barry D ^a   McAndrews, Joanne M ^a   Jordan, V Craig ^b   Jameson, J Larry ^a,b  

^a Division of Endocrinology   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Epidermal growth factor; Estrogen receptor; Reporter genes; Signal transduction

Indexed keywords

ANTIESTROGEN; EPIDERMAL GROWTH FACTOR; ESTRADIOL; ESTROGEN; FULVESTRANT; LUCIFERASE;

ARTICLE; BINDING AFFINITY; CANCER GROWTH; CONTROLLED STUDY; CROSS REACTION; DRUG INHIBITION; FEMALE; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

BREAST NEOPLASMS; CELL DIVISION; EPIDERMAL GROWTH FACTOR; ESTRADIOL; ESTROGEN RECEPTOR MODULATORS; FEMALE; GENES, REPORTER; HUMANS; LUCIFERASES; PLASMIDS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0033968739     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(99)00195-1     Document Type: Article

References (61)

1. Adachi K., Kurachi H., Homma H. et al. Estrogen induces epidermal growth factor (EGF) receptor and its ligands in human fallopian tube - involvement of EGF but not transforming growth factor-alpha in estrogen-induced tubal cell growth in vitro. Endocrinology. 136:1995;2110-2119.
2. Angel P., Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta. 1072:1991;129-157.
3. Aronica S.M., Katzenellenbogen B.S. Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-I. Mol. Endocrinol. 7:1993;743-752.
4. Berry M., Metzger D., Chambon P. Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen. EMBO J. 9:1990;2811-2818.
5. Berthois Y., Dong X.F., Martin P.M. Regulation of epidermal growth factor-receptor by estrogen and antiestrogen in the human breast cancer cell line MCF-7. Biochem. Biophys. Res. Comm. 159:1989;126-131.
6. Boonstra J., Rijken P., Humbel B., Cremers F., Verkleij A., ven Bergen en Henegouwen P. The epidermal growth factor. Cell. Biol. Int. 19:1995;413-430.
7. Bunone G., Briand P.A., Miksicek R.J., Picard D. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J. 15:1996;2174-2183.
8. Campbell M.J. Lipofection reagents prepared by a simple ethanol injection technique. Biotechniques. 18:1995;1027-1032.
9. Catherino W.H., Jordan V.C. Increasing the number of tandem estrogen response elements increases the estrogenic activity of a tamoxifen analogue. Cancer Lett. 92:1995;39-47.
10. Cormier E.M., Jordan V.C. Contrasting ability of antiestrogens to inhibit MCF-7 growth stimulated by estradiol or epidermal growth factor. Eur. J. Cancer Clin. Oncol. 25:1989;57-63.
11. Cormier E.M., Wolf M.F., Jordan V.C. Decrease in estradiol-stimulated progesterone receptor production in MCF-7 cells by epidermal growth factor and possible clinical implication for paracrine-regulated breast cancer growth. Cancer Res. 49:1989;576-580.
12. Cory A.H., Owen T.C., Barltrop J.A., Cory J.G. Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Comm. 3:1991;207-212.
13. Curtis S.W., Washburn T., Sewall C. et al. Physiological coupling of growth factor and steroid receptor signaling pathways - estrogen receptor knockout mice lack estrogen-like response to epidermal growth factor. Proc. Natl. Acad. Sci. USA. 93:1996;12626-12630.
14. Dickson R.B., Lippman M.E. Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma. Endocr. Rev. 8:1987;29-43.
15. Dowsett M., Macaulay V., Gledhill J. et al. Control of aromatase in breast cancer cells and its importance for tumor growth. J. Steroid Biochem. Mol. Biol. 44:1993;605-609.
16. El-Tanani M.K.K., Green C.D. Two separate mechanisms for ligand-independent activation of the estrogen receptor. Mol. Endocrinol. 11:1997;928-937.
17. Gaub M.P., Bellard M., Scheuer I., Chambon P., Sassone-Corsi P. Activation of the ovalbumin gene by the estrogen receptor involves the fos-jun complex. Cell. 63:1990;1267-1276.
18. Gehm B.D., McAndrews J.M., Chien P.-Y., Jameson J.L. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc. Natl. Acad. Sci. USA. 94:1997;14138-14143.
19. Gonzalez F., Lakshmanan J., Hoath S., Fisher D.A. Effect of oestradiol-17 beta on uterine epidermal growth factor concentration in immature mice. Acta Endocrinol. 105:1984;425-428.
20. Hafner F., Holler E., von Angerer E. Effect of growth factors on estrogen receptor mediated gene expression. J. Steroid Biochem. Mol. Biol. 58:1996;385-393.
21. Hyder S.M., Stancel G.M., Loose-Mitchell D.S. Presence of an estradiol response region in the mouse c-fos oncogene. Steroids. 56:1991;498-504.
22. Ignar-Trowbridge D.M., Nelson K.G., Bidwell M.C. et al. Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor. Proc. Natl. Acad. Sci. USA. 89:1992;4658-4662.
23. Ignar-Trowbridge D.M., Pimentel M., Parker M.G., McLachlan J.A., Korach K.S. Peptide growth factor cross-talk with the estrogen receptor requires the A/B domain and occurs independently of protein kinase C or estradiol. Endocrinology. 137:1996;1735-1744.
24. Ignar-Trowbridge D.M., Teng C.T., Ross K.A., Parker M.G., Korach K.S., McLachlan J.A. Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element. Mol. Endocrinol. 7:1993;992-998.
25. Jackson T.A., Richer J.K., Bain D.L., Takimoto G.S., Tung L., Horwitz K.B. The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors NCoR or SMRT. Mol. Endocrinol. 11:1997;693-705.
26. Jiang S.-Y., Wolf D.M., Yingling J.M., Chang C., Jordan V.C. An estrogen receptor positive MCF-7 clone that is resistant to antiestrogens and estradiol. Mol. Cell. Endocrinol. 90:1992;77-86.
27. rsk1 regulates estrogen receptor-mediated transcription through phosphorylation of Ser-167. Mol. Cell. Biol. 18:1998;1978-1984.
28. Jordan V.C., Murphy C.S. Endocrine pharmacology of antiestrogens as antitumor agents. Endocr. Rev. 11:1990;578-610.
29. Kato S., Endoh H., Masuhiro Y. et al. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science. 270:1995;1491-1494.
30. Kushner P.J., Baxter J.D., Duncan K.G. et al. Eukaryotic regulatory elements lurking in plasmid DNA - the activator protein-1 site in pUC. Mol. Endocrinol. 8:1994;405-407.
31. Lee A.V., Weng C.N., Jackson J.G., Yee D. Activation of estrogen receptor-mediated gene transcription by IGF-I in human breast cancer cells. J. Endocrinol. 152:1997;39-47.
32. Lees J.A., Fawell S.E., Parker M.G. Identification of constitutive and steroid-dependent transactivation domains in the mouse estrogen receptor. J. Steroid Biochem. 34:1989;33-39.
33. Lopez G., Schaufele F., Webb P., Holloway J.M., Baxter J.D., Kushner P.J. Positive and negative modulation of Jun action by thyroid hormone receptor at a unique AP1 site. Mol. Cell. Biol. 13:1993;3042-3049.
34. Ma Z.Q., Santagati S., Patrone C., Pollio G., Vegeto E., Maggi A. Insulin-like growth factors activate estrogen receptor to control the growth and differentiation of the human neuroblastoma cell line SK-ER3. Mol. Endocrinol. 8:1994;910-918.
35. Maxwell I.H., Harrison G.S., Wood W.M., Maxwell F. A DNA cassette containing a trimerized SV40 polyadenylation signal which efficiently blocks spurious plasmid-initiated transcription. Biotechniques. 7:1989;276-280.
36. McInerney E.M., Katzenellenbogen B.S. Different regions in activation function-1 of the human estrogen receptor required for antiestrogen- and estradiol-dependent transcription activation. J. Biol. Chem. 271:1996;24172-24178.
37. Metzger D., Ali S., Bornert J.M., Chambon P. Characterization of the amino-terminal transcriptional activation function of the human estrogen receptor in animal and yeast cells. J. Biol. Chem. 270:1995a;9535-9542.
38. Metzger D., Berry M., Ali S., Chambon P. Effect of antagonists on DNA binding properties of the human estrogen receptor in vitro and in vivo. Mol. Endocrinol. 9:1995b;579-591.
39. Mukku V.R., Stancel G.M. Regulation of epidermal growth factor receptors by estrogen. J. Biol. Chem. 260:1985;9380-9384.
40. Muller R., Bravo R., Burckhardt J., Curran T. Induction of c-fos gene and protein by growth factors precedes activation of c-myc. Nature. 312:1984;716-720.
41. Murphy C.S., Pink J.J., Jordan V.C. Characterization of a receptor-negative, hormone-nonresponsive clone derived from a T47D human breast cancer cell line kept under estrogen-free conditions. Cancer Res. 50:1990;7285-7292.
42. Nelson K.G., Takahashi T., Bossert N.L., Walmer D.K., McLachlan J.A. Epidermal growth factor replaces estrogen in the stimulation of female genital-tract growth and differentiation. Proc. Natl. Acad. Sci. USA. 88:1991;21-25.
43. Newton C.J., Buric R., Trapp T., Brockmeier S., Pagotto U., Stalla G.K. The unliganded estrogen receptor (ER) transduces growth factor signals. J. Steroid Biochem. Mol. Biol. 48:1994;481-486.
44. Promega Corporation, 1994. pGL3 Luciferase Reporter Vectors Technical Manual. Promega, Madison, WI.
45. Ram P.T., Kiefer T., Silverman M., Song Y., Brown G.M., Hill S.M. Estrogen receptor transactivation in MCF-7 breast cancer cells by melatonin and growth factors. Mol. Cell. Endocrinol. 141:1998;53-64.
46. Rose J.K., Buonocore L., Whitt M.A. A new cationic liposome reagent mediating nearly quantitative tranfection of animal cells. Biotechniques. 10:1991;520-525.
47. Ryde C.M., Nicholls J.E., Dowsett M. Steroid and growth factor modulation of aromatase activity in MCF-7 and T47D breast carcinoma cell lines. Cancer Res. 52:1992;1411-1415.
48. Smith C.L., Nawaz Z., O'Malley B.W. Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen. Mol. Endocrinol. 11:1997;657-666.
49. Smith C.S. Cross-talk between peptide growth factor and estrogen receptor signaling pathways. Biol. Reprod. 58:1998;627-632.
50. Sundaresan S., Colin I., Pestell R., Jameson J.L. Stimulation of mitogen-activated protein kinase by gonadotropin-releasing hormone: evidence for the involvement of protein kinase C. Endocrinology. 137:1996;304-311.
51. Teng C. Mouse lactoferrin gene: a marker for estrogen and epidermal growth factor. Environ. Health Perspect. 103(7):1995;17-20.
52. Tora L., White J., Brou C. et al. The human estrogen receptor has two independent nonacidic transcriptional activation functions. Cell. 59:1989;477-487.
53. Tzukerman M.T., Esty A., Santiso-Mere D. et al. Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol. Endocrinol. 8:1994;21-30.
54. Uht R.M., Anderson C.M., Webb P., Kushner P.J. Transcriptional activities of estrogen and glucocorticoid receptors are functionally integrated at the AP-1 response element. Endocrinology. 138:1997;2900-2908.
55. Umayahara Y., Kawamori R., Watada H. et al. Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP-1 enhancer. J. Biol. Chem. 269:1994;16433-16442.
56. Vanderboom R.J., Sheffield L.G. Estrogen enhances epidermal growth factor-induced DNA synthesis in mammary epithelial cells. J. Cell. Physiol. 156:1993;367-372.
57. Vignon F., Bouton M.M., Rochefort H. Antiestrogens inhibit the mitogenic effect of growth factors on breast cancer cells in the total absence of estrogens. Biochem. Biophys. Res. Comm. 146:1987;1502-1508.
58. Wagner B.L., Norris J.D., Knotts T.A., Weigel N.L., McDonnell D.P. The nuclear corepressors NCoR and SMRT are key regulators of both ligand- and 8-bromo-cyclic AMP-dependent transcriptional activity of the human progesterone receptor. Mol. Cell. Biol. 18:1998;1369-1378.
59. Webb P., Lopez G.N., Uht R.M., Kushner P.J. Tamoxifen activation of the estrogen receptor/AP-1 pathway - potential origin for the cell-specific estrogen-like effects of antiestrogens. Mol. Endocrinol. 9:1995;443-456.
60. Wood W.M., Kao M.Y., Gordon D.F., Ridgway E.C. Thyroid hormone regulates the mouse thyrotropin β-subunit gene promoter in transfected primary thyrotropes. J. Biol. Chem. 264:1989;14840-14847.
61. Wosikowski K., Kung W., Hasmann M., Loser R., Eppenberger U. Inhibition of growth-factor-activated proliferation by anti-estrogens and effects on early gene expression of MCF-7 cells. Int. J. Cancer. 53:1993;290-297.